<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">981</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>DIAGNOSTIC SIGNIFICANCE OF ADA (ADENOSINE DEAMINASE) IN TUBERCULOUS PLEURAL EFFUSION&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dave</surname><given-names>Kalpana K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Nikunj V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gonsai</surname><given-names>R.N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dangia</surname><given-names>Dimple J.</given-names></name></contrib></contrib-group><volume/><issue/><fpage>69</fpage><lpage>71</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Adenosine deaminase (ADA) is a useful biochemical parameter for tuberculous pleural effusion. Studies have confirmed diagnostic role of Adenosine deaminase for early diagnosis of pleural tuberculosis in high prevalence countries like India. Objective: To assess the diagnostic level of ADA in tubercular pleural effusion and to determine its Sensitivity, Specificity, Positive and Negative predictive value. Material and Methods: The Retrospective study was carried out on 51 patients suffering from pleural effusion in B.J.M.C. Ahmedabad during May to Aug-2012. Detailed clinical history, physical examination and routine investigation of all patients including ADA estimation by Galanti And Giusti method was done. Results : ADA level in tuberculous pleural effusion ranged from 25-160 U/L with a mean level of 72 U/L and at __ampersandsigngt;60 U/L the Sensitivity-69.2%, Specificity-92%, Positive Predictive Value-90% and Negative Predictive Value -74%. So this was best cut off point for ADA level to confirm diagnosis. Conclusion: ADA was found positive with a mean value of 72 U/L in tuberculous pleural effusion with 69.2% sensitivity and 92% specificity at cut off value of 60 U/L.&#13;
</p></abstract><kwd-group><kwd>Adenosine deaminase</kwd><kwd> Tuberculousis</kwd><kwd> Pleural effusion.</kwd></kwd-group></article-meta></front></article>
